Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market SWOT Analysis & Review - PowerPoint PPT Presentation

About This Presentation

Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market SWOT Analysis & Review


Prominent players profiled in FMI’s study on the market include*: Pfizer Inc. Alexion Pharmaceuticals Inc. BioMarin Pharmaceutical Inc. Ultragenyx Pharmaceutical Inc. Janssen Pharmaceuticals Inc. Sigma-Tau Pharmaceuticals Inc. AbbVie Inc. Sanofi SA – PowerPoint PPT presentation

Number of Views:37
Slides: 10
Provided by: Umesh213
Category: Other
Tags: ert_market


Transcript and Presenter's Notes

Title: Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market SWOT Analysis & Review


Gaucher and Pompe Diseases Enzyme Replacement
Therapy (ERT) Market 2021 Growth, COVID Impact,
Trends Analysis Report 2030
  • April 2021

Report Id   REP-GB-12771 Published On  
2020-11-26Category Healthcare, Pharmaceuticals
Medical Devices
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
Gaucher and Pompe Diseases Enzyme Replacement
Therapy (ERT) Market Analysis
  • The Gaucher and Pompe Disease ERT Market is
    anticipated to record a positive growth
    trajectory, despite facing a glitch in the
    initial months of COVID-19, due to rising orphan
    drug status designation to several drug
    candidates by the FDA. The market is further
    growing due to surge in number of partnerships
    and collaborations among key market players.
  • "Increase in regulatory approvals by government
    authorities is leading the entrance of prominent
    enzyme replacement therapy providers, therefore
    making huge revenue prospects all over promising
    markets," concludes the FMI analyst.
  • Request a report sample to gain comprehensive
    market insights at https//www.futuremarketinsight
  • Key Highlights
  • Europe to remain lucrative in the market,
    recording majority of the revenue share.
  • The type-1 Gaucher disease segment will record a
    significant growth pace amid the forecast period.
  • Parenteral administration remain highly preferred
    over oral route of administration.
  • Online pharmacies are likely to gain traction,
    growing at around 7 of CAGR during 2020-2030.

Gaucher and Pompe Diseases Enzyme Replacement
Therapy (ERT) Market Analysis
  • Drivers
  • Rising incidences of lysosomal storage disorders
    (LSD), across the globe is driving the market
  • Thriving orphan drug designations is anticipated
    to broaden the market scope over the assessment
  • Increasing prevalence of genetic disorders all
    over the world has boosted the growth in the
  • Restraints
  • Alternative treatment approaches for more
    efficient treatment is anticipated to hamper the
    market growth.
  • Presence of the pathological and blood-brain
    barrier preconditions further prove to be
    hindrances for efficient adoption of ERT.
  • For information on the Research Approach used in
    the Report, Request Methodology_at_ https//www.futur

Gaucher and Pompe Diseases Enzyme Replacement
Therapy (ERT) Market Analysis
COVID-19 Impact on the Market COVID-19 has
severely impacted the worldwide healthcare
sector. Regarding treatments and surgeries, key
priority is inclining towards COVID-19 positive
tested patients, bringing about postponement and
delays of some procedures. This has further
affected the Gaucher Pompe Disease ERT market,
registering a shortfall for hospital-based
treatment. However, the slowdown didnt lasted for
long, as government authorities leading
healthcare providers to continue treatment for
Type-3 and Type-1 Gaucher Disease
patients. Competitive Landscape The Gaucher
Pompe Disease ERT market is characterised by the
existence of a number of prominent pharmaceutical
and healthcare corporations, focusing on path
breaking technological advancements to present
more efficient therapeutic solutions on account
of strategic collaborations with several
Gaucher and Pompe Diseases Enzyme Replacement
Therapy (ERT) Market Analysis
Key players identified in the market are Pfizer
Inc., Tadeka Pharmaceuticals, BioMarin
Pharmaceutical Inc., Merck KGaA Alexion
Pharmaceuticals Inc., Janssen Pharmaceuticals
Inc., Sanofi SA, Ultragenyx Pharmaceutical Inc.,
Shire PLC,AbbVie Inc., and Sigma-Tau
Pharmaceuticals Inc. Contact Sales for Further
Assistance in Purchasing this Report_at_ https//www.
Gaucher and Pompe Diseases Enzyme Replacement
Therapy (ERT) Market Analysis
About the Study The study offers readers a
comprehensive assessment of the Gaucher and Pompe
Diseases Enzyme Replacement Therapy (ERT) Market.
Global, regional and national-level analysis of
the latest trends influencing the market is
covered in this FMI report. The study provides
insights on the basis of therapeutic condition
(Gaucher disease and Pompe disease), route of
administration (oral and parenteral) and
distribution channel (hospital pharmacies,
specialty treatment pharmacies, retail pharmacies
and online pharmacies), across key regions (North
America, Latin America, Europe, China, Asia
Pacific, Middle East Africa).
To know more about us, please visit our website For sales queries
or new topics email us on sales_at_futuremarketinsi For media queries, contact the press
office at For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)